American Biogenetic to grow through acquisitions
This article was originally published in Clinica
Executive Summary
American Biogenetic Sciences plans to strengthen its diagnostics division through the acquisition of products and/or access to distribution channels. The move is intended to help the transition from a development-stage company to a fully integrated diagnostics business.